During cardiogenesis, cardiomyocytes become specialized to exhibit ventricular, atrial or pacemaker properties 1 . Pacemaker cells are exceedingly rare, accounting for <10,000 of the ~10 billion cells (including myocytes and nonmyocytes) in the adult mammalian heart 2 . Yet the initiation of the heartbeat depends critically upon this subpopulation. Failure of the native pacemaker in the sinoatrial node (SAN) due to aging or genetic disease causes disturbances in cardiac rhythm, leading to syncope and circulatory collapse. Current therapy for such bradyarrhythmias relies on costly electronic devices. A decade-long search for biological alternatives has focused either on eliciting automaticity, that is, spontaneous oscillation of action potentials, from quiescent cardiomyocytes by genetic manipulation of sarcolemmal ionic currents 3-5 , or on deriving spontaneously beating embryoid bodies from human embryonic stem cells 6, 7 . Efforts to manipulate sarcolemmal ionic currents are limited to adding or subtracting one ionic current and do not faithfully replicate the delicate physiology and unique morphological features of genuine SAN pacemaker cells. Challenges with the human embryonic stem cell approach include heterogeneity of the derived cardiac cells and the persistent risk of tumorigenicity 8 . We hypothesized that quiescent ventricular myocytes might be converted to pacemaker cells by ectopic expression of one or more transcription factors. The obvious candidates are known transcriptional regulators of embryonic SAN development, particularly Shox2, Tbx3, Tbx5 and Tbx18 (ref. 9). Shox2 is a negative regulator of Nkx2.5 in the sinus venosus, and Shox2-deficient mouse and zebrafish embryos display bradycardia 10,11 . Tbx3 is a potent regulator of SAN specialization, with developmental errors resulting from either deficiency or ectopic expression 12 . Tbx5, which shows an inverse correlation between its dosage and abnormal cardiac morphogenesis in Holt-Oram syndrome, is a positive regulator of Shox2 and Tbx3 (ref. 13). Upstream of all these factors is Tbx18. Mesenchymal progenitor cells expressing Tbx18 define the sinus venosus and differentiate de novo into sinoatrial nodal cells. Tbx18 is required for embryonic development of the SAN head area 14 but becomes undetectable by birth and in adulthood (Supplementary Fig. 1) .
A r t i c l e s
During cardiogenesis, cardiomyocytes become specialized to exhibit ventricular, atrial or pacemaker properties 1 . Pacemaker cells are exceedingly rare, accounting for <10,000 of the ~10 billion cells (including myocytes and nonmyocytes) in the adult mammalian heart 2 . Yet the initiation of the heartbeat depends critically upon this subpopulation. Failure of the native pacemaker in the sinoatrial node (SAN) due to aging or genetic disease causes disturbances in cardiac rhythm, leading to syncope and circulatory collapse. Current therapy for such bradyarrhythmias relies on costly electronic devices. A decade-long search for biological alternatives has focused either on eliciting automaticity, that is, spontaneous oscillation of action potentials, from quiescent cardiomyocytes by genetic manipulation of sarcolemmal ionic currents [3] [4] [5] , or on deriving spontaneously beating embryoid bodies from human embryonic stem cells 6, 7 . Efforts to manipulate sarcolemmal ionic currents are limited to adding or subtracting one ionic current and do not faithfully replicate the delicate physiology and unique morphological features of genuine SAN pacemaker cells. Challenges with the human embryonic stem cell approach include heterogeneity of the derived cardiac cells and the persistent risk of tumorigenicity 8 . We hypothesized that quiescent ventricular myocytes might be converted to pacemaker cells by ectopic expression of one or more transcription factors. The obvious candidates are known transcriptional regulators of embryonic SAN development, particularly Shox2, Tbx3, Tbx5 and Tbx18 (ref. 9) . Shox2 is a negative regulator of Nkx2.5 in the sinus venosus, and Shox2-deficient mouse and zebrafish embryos display bradycardia 10, 11 . Tbx3 is a potent regulator of SAN specialization, with developmental errors resulting from either deficiency or ectopic expression 12 . Tbx5, which shows an inverse correlation between its dosage and abnormal cardiac morphogenesis in Holt-Oram syndrome, is a positive regulator of Shox2 and Tbx3 (ref. 13) . Upstream of all these factors is Tbx18. Mesenchymal progenitor cells expressing Tbx18 define the sinus venosus and differentiate de novo into sinoatrial nodal cells. Tbx18 is required for embryonic development of the SAN head area 14 but becomes undetectable by birth and in adulthood (Supplementary Fig. 1 ).
We expressed various embryonic SAN transcription factors in postnatal ventricular rodent cardiomyocytes via adenoviral vectors and found that Tbx18 converts ventricular myocytes to faithful replicas of SAN pacemaker cells in vitro and in vivo. The iSAN cells exhibit automaticity and pacemaker cell morphology, and function as biological pacemakers in vivo. Specific epigenetic changes in the cells are consistent with direct and specific transformation rather than nonspecific reversion to a primitive state. iSAN cells retain their phenotype even after the expression of exogenous Tbx18 has waned, indicating durable conversion to a pacemaker phenotype.
RESULTS

Tbx18 increases automaticity in neonatal cardiomyocytes
Freshly isolated neonatal rat ventricular myocytes (NRVMs) were transduced individually with bicistronic adenoviral vectors expressing transcription factor genes implicated in cardiac development (Shox2, Tbx3, Tbx5, Tbx18 and Tbx20). We analyzed the number of spontaneously beating cultures 36-48 h after transduction as an initial screen. Tbx18-transduced NRVMs (Tbx18-NRVMs) formed a higher percentage of spontaneously beating monolayer cultures compared to GFP-NRVM control and to NRVMs transduced by any of the other tested transcription factor genes (a minimum of five independent NRVM isolations per group, Fig. 1a) . Beyond 2 d of culture, multiple, spontaneously beating foci could often be observed in individual Tbx18-NRVM monolayers, as expected from the downregulation of Cx43 (but not Cx45 or Cx40) by Tbx18 (ref. 15) . Accordingly, we focused on Tbx18 as a candidate for converting ventricular cardiomyocytes to pacemaker cells, with a view to establishing the fidelity of conversion by detailed physiological, morphological and epigenetic characterization. 
A r t i c l e s
Tbx18 induces 'voltage clock' mechanisms of automaticity Although NRVMs have spontaneous, syncytial contractions when cultured as monolayers, this phenomenon is driven by a relatively small number of autonomously beating cells 15 . When sparsely plated at a density of ~4 NRVMs/mm 2 such that a given cell was unlikely to physically contact neighboring cells, a majority of the control (transduced singly with GFP) ventricular myocytes were quiescent, firing single action potentials only upon stimulation (Fig. 1b, left) . Tbx18 expression changed the electrical phenotype to that of SAN pacemaker cells 16 ; most Tbx18-NRVMs beat autonomously and spontaneously (Fig. 1b, right) . The maximum diastolic potential of −47 ± 10 mV (n = 6) in Tbx18-NRVMs was depolarized relative to the resting membrane potential of −73 ± 6 mV in GFP-NRVMs (n = 5, Fig. 1c, left) . Underlying this depolarization was a 78% reduction in the density of an inwardly rectifying K + current, I K1 , in Tbx18-NRVMs (n = 6 for Tbx18-NRVMs and n = 5 for GFP-NRVMs, Fig. 1d ). An index of automaticity, defined as the percentage of autonomously beating cells multiplied by the frequency of action potential oscillations in those cells (Fig. 1c, legend) , was much larger in Tbx18-NRVMs (70 ± 16% beats/min (b.p.m.)) compared to GFP-NRVM control (13 ± 4% b.p.m., Fig. 1c, middle) . Likewise, the number of Tbx18-NRVMs exhibiting spontaneous intracellular Ca 2+ oscillations was about sixfold higher relative to GFP-NRVM control ( Fig. 1c, right; Supplementary Movies 1 and 2) .
Gradual and spontaneous depolarization of the membrane potential, termed phase-4 depolarization, underlies automaticity in SAN pacemaker cells 16 and was prominent in Tbx18-NRVMs (Fig. 1b) . HCN4 ion channel conducts the hyperpolarization-activated current, I f , which contributes to pacemaker activity in the SAN 17 . Tbx18 expression led to a 3.8-fold increase in the number of cells expressing HCN4 (Fig. 1e) , and a 1.4-fold increase in the HCN4 protein level (Fig. 1f) in Tbx18-NRVMs. Such cells also exhibited I f (Fig. 1g) at a density (−1.9 ± 0.8 pA/pF at −50 mV, n = 3) consistent with that reported in rabbit SAN cells 18, 19 . Intracellular Ca 2+ cycling events complement and couple with sarcolemmal ionic currents to generate automaticity 20 . Comparison of transcript levels for selected components of the voltage-and calcium-dependent mechanisms revealed differences in Tbx18-NRVMs versus GFP-NRVMs, which closely recapitulate those between native SAN cells and ventricular myocardium in rat, used here as positive controls (Fig. 1h) .
Tbx18 induces 'Ca 2+ clock' mechanisms of automaticity Whereas membrane-delimited electrophysiological pathways contribute to pacemaking, SAN cells are also triggered to fire rhythmically by finely orchestrated, distinctive intracellular Ca 2+ cycling events. Subsarcolemmal, spontaneous local Ca 2+ release events (LCRs) are a hallmark of automaticity in SAN cells 20 . During late diastole, LCRs activate Na + -Ca 2+ exchanger currents (I NCX ), which then contribute to the exponential rise of phase-4 depolarization 20 . Line-scan confocal imaging of Tbx18-NRVMs resolved LCRs preceding each whole-cell Ca 2+ transient (Fig. 2a , n = 8 out of 10 cells), recapitulating the LCRs observed in native SAN pacemakers 21 . Tbx18-NRVMs exhibited wider and longer-lasting LCRs compared to the spontaneous Ca 2+ release events in GFP-NRVMs, but the amplitudes were identical (Fig. 2a-c) . 
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The LCRs in Tbx18-NRVMs occurred at an average period of 343 ± 8 ms, which was 72 ± 1% of the whole-cell Ca 2+ transient cycle length (474 ± 7 ms, Fig. 2d ). In contrast, GFP control NRVMs did not have any regular LCRs (n = 12 out of 12 cells), but only occasional, randomly distributed sparks (e.g., Fig. 2b ). Larger Ca 2+ stores in the sarcoplasmic reticulum would favor automaticity 20 . The amplitude of caffeine-induced Ca 2+ transients was 2.3-fold larger in Tbx18-NRVMs compared to GFP-NRVM control (Fig. 2e) . The Ca 2+ release channel blocker, ryanodine (10 µM), suppressed the rate of spontaneous Ca 2+ transients by 47 ± 6% in Tbx18-NRVMs but only by 12 ± 2% in the GFP-NRVM control (Fig. 2f) . Phospholamban (PLB), in its unphosphorylated state, inhibits sarcoplasmic reticulum Ca 2+ -ATPase 2a (SERCA2a), thereby suppressing the reuptake of Ca 2+ by internal stores 20 . Such inhibition is relieved by phosphorylation of the protein (p-PLB). The relative p-PLB (Ser16) level was 65-fold higher in Tbx18-NRVMs in comparison to GFP-NRVMs (n = 4, Fig. 2g , left panel), reproducing the augmentation of p-PLB found in the SAN compared to that in the ventricular myocardium (n = 4, Fig. 2g , right panel) 22 . Consistent with findings in the rabbit SAN versus the left ventricle 23 , the protein levels of SERCA2a, NCX1 and ryanodine receptor (RyR) remained similar between Tbx18-and GFP-NRVMs (n = 5, Fig. 2h ). Intracellular cAMP levels were 1.7-fold higher in Tbx18-NRVMs compared to GFP-NRVMs (n = 3, Fig. 2i ), reproducing the higher [cAMP] i observed in the rabbit SAN compared to ventricular myocardium 22 . Application of a PKA inhibitor (15 µM) led to cessation of spontaneous whole-cell Ca 2+ transients in Tbx18-NRVMs, but had no effect on GFP-NRVMs (Fig. 2j) . Thus, Tbx18 expression in NRVMs produced distinctive changes in Ca 2+ cycling that recapitulate key features of SAN pacemaker cells.
Tbx18 converts myocyte morphology to that of SAN cells
We posited that faithful conversion should replicate not only the electrophysiology but also key features of cell structure in pacemaker tissue. Native SAN pacemaker cells have a distinctive morphology. They are smaller 24 and exhibit less-organized myofibrils 2,25 than working cardiomyocytes. Sections of neonatal rat heart showed that cardiac sarcomeric α-actinin (α-SA) expression was markedly lower and disorganized in the SAN compared to the adjacent right atrium (Fig. 3a , top left and bottom left). Tbx18-NRVMs resembled native SAN cells in their morphology, with myofibrillar disorganization and weak expression of α-SA (Fig. 3a, bottom right) . The data are corroborated by the observed downregulation of α-SA transcript levels in Tbx18-NRVMs (Fig. 1h) . Cell size, measured by two complementary methods, was 28-33% smaller in Tbx18-NRVMs than in GFP control NRVMs (Fig. 3b) , recapitulating the smaller size of SAN cells relative to working cardiomyocytes 24 . Thus, Tbx18-NRVMs underwent both structural (morphological) as well as functional (electrophysiological) conversion. 
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Tbx18 induces SAN-specific epigenetic changes Trimethylation of lysine 27 in histone 3 (H3K27me3) is a heterochromatin mark that promotes the recruitment of Polycomb group proteins for gene silencing 26 . Conversely, trimethylation of lysine 4 (H3K4me3) marks genes as transcriptionally active 27 . We analyzed histone modification profiles in the promoter regions of four genes, Gja1, Kcnj2, Actc2 and Hcn4, which exhibit relevant molecular and functional changes in Tbx18-NRVMs. Chromatin immunoprecipitation followed by quantitative (q)PCR indicated that the promoter regions of Gja1, Kcnj2 and Actc2 became epigenetically inactive (higher H3K27me3 and lower H3K4me3) in Tbx18-NRVMs compared to GFP-NRVM control (Fig. 3c) . In contrast, Tbx18 overexpression led to epigenetic activation of the Hcn4 promoter (Fig. 3c) , underlying heightened HCN4 function in Tbx18-NRVMs (Fig. 1e-g ). Thus, the epigenetic chromatin histone modifications were consistent with specific conversion to SAN-like pacemaker cells rather than nonspecific dedifferentiation.
iSAN cells, created in situ, function as pacemakers in vivo
To examine potential conversion of adult ventricular myocytes into pacemaker cells in vivo, we directly and focally injected Tbx18 adenoviral vector into the apex of guinea-pig hearts. Tbx18 transduction in the injected region was strong and focal ( Supplementary Fig. 2 ). Two to four days after injection, we looked for ectopic pacemaker activity by electrocardiography. Upon suppression of the native sinus rhythm with methacholine 28, 29 , five of five control (GFP-injected) animals exhibited a slow junctional rhythm with antegrade polarity and narrow QRS duration (Fig. 3d,e and Supplementary Fig. 3 ). Under the same conditions, five of seven Tbx18-injected animals demonstrated an ectopic ventricular rhythm with wide QRS complexes and retrograde polarity (Supplementary Fig. 3 ). Electrocardiographic vector analysis 30 verified that such ectopic beats initiated from the apex in Tbx18-injected animals, but not in GFP-injected animals (Fig. 3d, bottom panels) .
To ascertain that the ectopic pacemaker activity originated from indicates that Tbx18 increased inactivity of Gja1, Kcnj2, and Actn2 promoters while relieving its repressive epigenetic pressure on Hcn4 promoter normalized to GFP-NRVM control. Meanwhile, H3K4me3 levels indicate that ratio of active Hcn4 promoter regions increased upon Tbx18 expression while the transcriptionally active promoter regions of Gja1, Kcnj2, and Actn2 have decreased upon Tbx18 expression. (n = 3 experiments. For each experiment, NRVMs from 6 wells of a 6-well plate were isolated for each group.) (d) Focal expression of Tbx18 in the apex of guinea pig hearts in vivo created ectopic ventricular beats. Representative electrocardiographs (lead II) of GFP-or Tbx18-injected guinea pig (left and right, respectively, top panels). Ectopic ventricular pacemaker activity was observed in Tbx18-injected guinea pigs, but not in GFPguinea pigs. Heart axis plots (bottom panels) suggest that the ectopic beats in Tbx18-guinea pig (right) originated near the site of gene injection (apex) and propagated toward the base. In contrast, the escape beats in GFP-injected control guinea pigs propagated toward the apex from the atrioventricular junction (left, n = 5 for GFP-guinea pig and n = 7 for Tbx18-guinea pig). (e) The rate of ectopic ventricular beats upon methacholine-induced suppression of the animals' sinus rhythm at day 3-5 after gene delivery is significantly higher in Tbx18-injected animals than in GFP-injected animals. Error bars, mean ± s.d.
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Tbx18-transduced ventricular myocytes (Tbx18-VMs), we characterized single cardiomyocytes isolated 4-6 d after direct injection of Tbx18 (or GFP) in vivo and compared them to isolated native SAN cells. Tbx18-VMs faithfully reproduced the distinctive tapering morphology of SAN cells (Fig. 4a) ; in contrast, nontransduced and GFP-VMs retained the bricklike appearance typical of ventricular myocytes. Native SAN cells were smaller and thinner than nontransduced VMs (Fig. 4b) . GFP-VMs maintained their native shape, whereas Tbx18-VMs were thinner and frequently spindle-shaped (Fig. 4a-b and Supplementary  Fig. 4a ). GFP-VMs exhibited stable resting potentials at −83.6 ± 1.7 mV (n = 6), with action potentials elicited only upon electrical stimulation (Fig. 4c, right panel) . In contrast, Tbx18-VMs fired spontaneous, rhythmic action potentials with prominent diastolic depolarization like that in native SAN cells (Fig. 4c, middle and left panels, respectively) . The electrophysiological parameters (maximum diastolic potential, APD 90 , V max , beating rate) of Tbx18-VMs (n = 5) closely resembled those of native SAN pacemaker cells (n = 6, Fig. 4d ).
De novo automaticity responds to autonomic regulation SAN pacemaker cells respond to autonomic inputs with altered firing rates. To assess adrenergic and muscarinic responses in iSAN cells, we plated Tbx18-or GFP-NRVMs on multi-electrode arrays to record extracellular field potentials from spontaneously beating cells (Fig. 5a) . Beta-adrenergic stimulation (with 1 µM isoproterenol) increased the firing rates of Tbx18-NRVMs from 101 ± 30 b.p.m. to 183 ± 44 b.p.m. (n = 12, P < 0.05). Subsequent exposure to a cholinergic agonist, acetylcholine (1 µM), suppressed the rate to 69 ± 33 b.p.m. (n = 12, P < 0.05, Fig. 5b,c) . In contrast, GFP-NRVMs had a very slow spontaneous beating rate, which changed little with either isoproterenol or acetylcholine (Fig. 5b,c) .
Immunostaining confirmed prominent expression of β-adrenergic receptors and muscarinic receptor type 2 in Tbx18-NRVMs (Fig. 5d) . Thus, Tbx18-NRVMs responded appropriately to adrenergic and muscarinic stimuli.
To investigate autonomic regulation of induced biological pacemakers in the intact heart, we created a disease model in guinea pigs of atrioventricular block, a common indication for the placement of an electronic pacemaker, by cryoablation of the atrioventricular node. Electrocardiographic recordings of the beating hearts, perfused ex vivo (Supplementary Fig. 5 ), revealed ectopic ventricular beats in eight of eight Tbx18-injected hearts, at a rate of 154 ± 6 b.p.m. The polarity and morphology of the ectopic beats was 
identical to that of electrode-paced beats at the location of transgene injection (Fig. 5e) , linking the origin of the ectopic beats to the site of Tbx18 transduction. Conversely, most GFP-injected control hearts showed a narrow-QRS junctional escape rhythm at an average rate of 120 ± 7 b.p.m. (n = 7/10), which originated on the opposite end of the ventricle (Fig. 5f) . Tbx18-injected hearts responded well to autonomic regulation; β-adrenergic stimulation followed by cholinergic suppression increased and then decreased the heart rate to 235 ± 19 b.p.m. and then to 150 ± 23 b.p.m., respectively (n = 7, Fig. 5g) . Collectively, these data demonstrated that iSAN cells respond to autonomic regulation in vitro and in the intact heart with proper chronotropy.
The iSAN phenotype persists beyond Tbx18 expression Reprogrammed cells are defined as remaining stably altered without sustained expression of exogenous transcription factors 31, 32 . To investigate the persistence of the iSAN phenotype, we examined Tbx18-VMs isolated 6-8 weeks after the initial in vivo gene transfer and quantified the transcript levels of Tbx18 by single-cell qRT-PCR. Tbx18 transcripts exhibited a wide dynamic detection range in Tbx18-VMs isolated just 3 d after in vivo gene transfer (Fig. 6a, bottom panel) . To examine the durability of conversion to iSAN cells, we identified five spontaneously beating ventricular myocytes (114 ± 10 b.p.m. by live-cell video recording or whole-cell patch-clamp) isolated 6-8 weeks after in vivo gene transfer. PCR primer sets were designed to detect Tbx18, cardiac troponin T (Tnnt2, to verify cardiomyocyte identity) and Gapdh. The levels of Tbx18 transcript in four of the five spontaneously beating myocytes were negligible (Fig. 6b,  cell 1, 2, 3 and 4, bottom panel) , close to the negative control level (Fig. 6c) in ventricular myocytes expressing GFP alone. Taking the cell length-to-width (L-to-W) ratio as the criterion, we examined the percentage of iSAN cells up to 6 weeks after initial gene transfer. A significant proportion of iSAN cells persisted, although the percentage tended to decline over time (Supplementary Fig. 4b ). The latter finding is not surprising given that adenovirally transduced cells are cleared by the animal's immune system. Tbx18 was directly injected into the apex of a guinea pig heart in vivo. Seven days post-injection, the heart was harvest, perfused, and cryoablated at the atrioventricular junctional region. The polarity and morphology of the ectopic beats (left panel) is identical to those of electrode-paced beats at the site of transgene injection (right). (f) In contrast, most GFP-injected control hearts (7/10) showed a narrow-QRS junctional escape rhythm (left panel), which were opposite in polarity and morphology to those of electrode-paced beats at the apex (right panel). (g) Chronotropic response of Tbx18-injected hearts to autonomic inputs was assessed by changing the perfusate (normal Tyrode's solution) to one that containing 1 µM isoproterenol for β-adrenergic stimulation followed by one that containing 1 µM acetylcholine for cholinergic suppression. Error bars, mean ± s.e.m.
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We looked for persistence of the induced pacemaker phenotype beyond the first few days of transduction using the perfused intact heart atrioventricular block model. Three to four weeks after gene transfer, Tbx18-injected hearts demonstrated ectopic idioventricular rhythm at 165 ± 14 b.p.m. (n = 3/3, Supplementary Fig. 6a) , with electrocardiograms consistent with biological pacing from the Tbx18 injection site (Supplementary Fig. 6b) . Furthermore, these hearts responded to autonomic regulation (Supplementary Fig. 6c ) in a manner similar to the short-term, Tbx18-injected hearts (Fig. 5g) . Taken together, the data indicate that iSAN cells maintain pacemaker function even after exogenous Tbx18 expression has waned, indicative of genuine reprogramming.
iSAN cells are not dedifferentiated cardiomyocytes Tbx18 has been argued to be a marker of ventricular progenitors in cardiac development 33, 34 , and has been associated with neoplasia 35 . In addition, fetal cardiomyocytes have been shown to possess transient beating capacity, which is lost soon after birth 36, 37 . However, the morphology of iSAN cells is incompatible with nonspecific regression. Dedifferentiating adult VMs lose their longitudinal, 'bricklike' shape and become rather circular, similar to their neonatal counterparts, but do not become thinner 38 . Nonetheless, the following arguments support Tbx18-induced specific conversion rather than reversion to a fetal state. First, dedifferentiation is accompanied by reexpression of gene products characteristic of the fetal heart, including atrial natriuretic peptide (ANP) and skeletal α-actin (αSkA) 39 . Neither ANP nor αSkA was reexpressed in Tbx18-NRVMs; in fact, ANP expression was strongly suppressed (Supplementary Figs. 7 and   8 , respectively), recapitulating the known absence of ANP in native SAN 40, 41 . Second, dedifferentiation would bring the transduced myocytes closer to a progenitor state, and expression of early ventricular transcription factors such as Nkx2-5 (refs. 42,43) would be enhanced. Instead, Tbx18 lowered the transcript level of Nkx2-5 (Fig. 1h) , consistent with conversion to mature pacemaker cells 44 but not reversion to a fetal state. Third, if the de novo automaticity of Tbx18-NRVMs were a consequence of dedifferentiation to an embryonic and/or fetal state, the proliferative index of the cells would be expected to increase 38 . This is because the embryonic ventricle grows by hyperplasia, an ability that plummets after birth 45, 46 . On the contrary, phosphohistone 3 (H3P, a mitotically active cell marker) expression and EdU (an analog of BrdU, a marker for mitosis and nascent DNA synthesis) incorporation were comparable in Tbx18-and GFP-NRVMs (n = 3, Supplementary Fig. 9 ). Finally, reversion to an embryonic state would be expected to require extensive epigenetic changes 47 . Investigation of 84 genes related to chromatin remodeling identified only minor global differences between Tbx18-NRVMs and GFPNRVMs (Supplementary Fig. 10 ). We further examined 84 genes related to stemness and verified that Tbx18-NRVMs remained differentiated with no discernible increase in stemness or decrease in differentiation factors 3-5 d after transduction ( Supplementary  Fig. 11) . The ability to reprogram adult ventricular myocytes in vivo so as to faithfully replicate SAN cells further argues against dedifferentiation. Taken together with the previously noted histone 3 trimethylation changes in SAN-marker genes Gja1, Kcnj2, Actn2 and Hcn4 (Fig. 3c) , the data support Tbx18-induced specific conversion rather than dedifferentiation. npg DISCUSSION We report highly effective conversion of postnatal ventricular myocytes to SAN-like pacemaker cells by a single transcription factor. In a brief span of 2-4 d, Tbx18 created de novo automaticity in ventricular myocytes by specific modulation of membrane-and calcium-clock pathways and cell morphology. Myofibrillar structure was disrupted, cell size shrank and cells became thin and tapered in Tbx18-VMs and Tbx18-NRVMs, recapitulating distinctive features of SAN pacemaker cells. Given the evidence for durable and specific reprogramming, we propose to call these engineered pacemakers iSAN cells, consistent with previous nomenclature in the reprogramming field. Table 1 compares the Tbx18-induced changes to known differences between natural pacemaker tissue and working heart muscle. All key features of the native pacemaker are reproduced in iSAN cells. Direct conversion of ventricular myocytes to pacemaker cells by Tbx18 obviates the need for passage through a pluripotent state. Previous examples of direct lineage conversion include reprogramming of fibroblasts and other cell types into skeletal muscle cells 48 , of exocrine cells into insulin-producing endocrine cells in the mouse pancreas 49 , and of fibroblasts into neurons 50 , cardiomyocytes 51, 52 and blood cell progenitors 53 . In our work, a single transcription factor suffices for direct conversion to iSAN cells. The process is specific and highly efficient, allowing reprogramming in situ and biological pacemaker function in vivo. A recent study in transgenic mice expressing Tbx3 observed enhanced automaticity in Tbx3-expressing ventricular myocytes, but did not create biological pacemaker activity in vivo 54 . In contrast, Tbx18 expression by somatic gene transfer creates biological pacemaker function in vivo (Fig. 3d,e) and is superior to Tbx3 in generating automaticity in vitro (Fig. 1a) .
The faithful recapitulation of the sophisticated pacemaker cell phenotype by Tbx18 contrasts with previously functional approaches, which created biological pacemakers by manipulating end-effectors of sarcolemmal electrophysiology 4, 5 . The present approach produces cells that not only oscillate electrically but also exhibit the fine nuances of calcium clock behavior and distinctive morphological features of genuine SAN pacemakers. This technology thus represents a promising alternative to electronic pacing devices. From a practical viewpoint, our observations suggest two strategies for creating biological pacemakers as alternatives to electronic devices 3 : (i) focal transduction of the heart with an appropriate vector expressing Tbx18, or (ii) ex vivo creation of iSAN cells with subsequent transplantation into the heart, as an alternative to pluripotent stem cell-derived pacemakers 6, 7 . Longer-term experiments in large-animal models will be required to assess safety and efficacy before translation to patients with bradycardia.
METHODS
Methods and any associated references are available in the online version of the paper. npg were anesthetized with 4% isoflurane, intubated, and placed on a ventilator with a vaporizer supplying 1.5% to 2% isoflurane. After lateral thoracotomy, a 30-gauge needle was inserted at the free wall apex of the left ventricle. 100 µl of adenovirus containing 1 × 10 9 fluorescence-forming units of Ad-Tbx18-IRES-GFP or Ad-GFP (control group) was injected into the left ventricle apex. We performed flow cytometry on live, freshly isolated adult guinea pig ventricular cardiomyocytes one week after direct intramyocardial injection of Tbx18-IRES-GFP adenovirus. The total number of Tbx18-transduced ventricular myocytes (gated for large cell size and GFP + ) is estimated to be 23,000 ± 12,000 myocytes per heart (n = 3). Animals for the long-term studies were treated with cyclosporine A (10 mg/kg/24 h) by daily IP injection or with an implantable subcutaneous osmotic pump so as to lessen clearance of transduced cardiomyocytes by the animal's immune system.
In vivo and ex vivo electrocardiographic recordings. Methacholine (0.1-0.5 mg per kg of body weight in saline, Sigma-Aldrich, St. Louis, MO) was delivered via the jugular vein in order to slow the animals' sinus rhythm before ECG recordings under general anesthesia (2% isoflurane, 98% O2). Lead I and Lead II ECGs were recorded analyzed at 2 kHz with a PowerLab Data Acquisition System and a LabChart software (ADInstruments Inc.). In all animals, methacholine was administered until complete heart block was achieved with accompanying reduction of the animals' sinus rhythm to <100 b.p.m.
In most of the Tbx18-injected guinea pigs, ectopic ventricular rhythms were manifested well before the sinus rhythm reached 100 b.p.m. (Fig. 3d, right  panel) . In contrast, control animals exhibited no evidence of such ectopic ventricular beats even when the sinus rhythm was brought to <100 b.p.m. (Fig. 3d, left panel) . Figure 3d highlights the lack of any ectopic ventricular rhythm in the control animals even at a very slow escape rate compared to Tbx18-injected animals.
For ex vivo, intact whole-heart ECG recordings, the heart was retrogradeperfused via aorta at 60 mm Hg with oxygenated Tyrode's solution at 36 °C. The perfused heart was placed in a sylgard-coated plate filled with warm Tyrode's solution. ECG leads were stationed at appropriate sites to record leads I and II (Supplementary Fig. 5) . After a 20-min equilibration period, the region of atrioventricular node was ablated with a cryogun (Brymill Cryogenic Systems, Ellington, CT) filled with liquid N 2 . Electrode-pacing was performed at the site of transgene injection (anterior, left ventricular apex) at 200-ms intervals with a platinum electrode connected to an isolated pulse stimulator (Model 2100, A-M Systems, Carlsborg, WA).
RT-PCR for gene arrays. Rat SAN, Left ventricle and Tbx18-and GFPtransduced NRVMs (4 days after transduction) were collected and mRNA was extracted (Qiagen mRNA Isolation Kit,). The mRNA samples were converted to first strand cDNA, using the RT2 First Strand Kit. (SA Biosciences). Then, the cDNA template was mixed with the RT2 qPCR Master Mix and the mixture was aliquoted into each well of the same plate containing pre-dispensed gene specific primer sets. PCR was performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems/Life Technologies Corporation, Carlsbad, CA) and the relative expression of the genes was calculated. cAMP assay. The Cyclic AMP Elisa Assay Kit (catalog # STA-501; Cell Biolabs, INC) was used to determine cAMP levels in NRVMs transduced with AdTbx18 or Ad-GFP. Briefly, 50 µl Tbx18-and GFP-NRVM cell lysates were added to the Goat Anti-Rabbit Antibody Coated Plate 96 well plate. 25 µL of diluted Peroxidase cAMP Tracer Conjugate was added to each tested well. Then, 50 µL of diluted Rabbit Anti-cAMP Polyclonal Antibody was added to each tested well and the plate was incubated at room temperature for 30 min with shaking. After washing 100 µL of Chemiluminescent Reagent was added to each well. After incubation at room temperature for 5 min on an orbital shaker, the plate was read for luminescence of each microwell on a plate luminometer. Measurement of light emission (RLU) allowed calculating the amount of cAMP in samples which were then normalized to β-actin for comparison of the samples.
Chromatin immunoprecipitation and qPCR. NRVMs transduced with either Tbx18 or GFP were fixed two-to four-days after viral vector transduction with 10% formaldehyde for 8 min at room temperature. Cells were sheared using a sonicator with ten pulses of 20 s each, with a 30-s rest on ice between each pulse. Chromatin immunoprecipitation was performed using ChIP-IT Express Chromatin Immunoprecipitation kit (Active Motif, Carlsbad, CA) following the manufacturer's protocol. Primary antibodies for the H3K4me3 and H3K27me3 were purchased from Active Motif. Gene specific (Cx43, Kir2.1, α-SA, HCN4) primers, already validated for qPCR in rat, were purchased from SA Biosciences. For each gene, three sets of primers were employed corresponding to −2 kb (upstream), −1 kb, and +1 kb (downstream) of the transcription start site. The ∆Ct values from the three tiles were averaged from each experiment for data analyses.
Single-cell quantitative real-time PCR. Single myocytes were collected in PBS with a wide-opening patch pipette, placed on dry ice and then stored at −80 °C. Tbx18 mRNA levels in individual myocytes were examined by quantitative real-time PCR with an Ambion Single Cell-to-CT Kit (Life Technologies) according to manufacturer's instructions. Briefly, single cells were treated with cell lysis solution and DNase I for 5 min at room temperature. Reverse transcription was performed at 25 °C for 10 min, at 42 °C for 60 min and at 85 °C for 5 min after addition of SupersScript RT and VILO RT mix. Preamplification was performed with 14 cycles of 95 °C for 15 s and 60 °C for 4 min with addition of PreAmp mix and 0.2x TaqMan Gene Expression Assays, containing primers for human Tbx18 (assay ID:Hs01385457_m1), guinea pig GAPDH (assay ID:Cp03755742_g1), and guinea pig TnnT2 (assay ID:Cp04182357_g1). The custom primers were synthesized by Applied Biosystems (Carlsbad, CA). Preamplification products (1:20 dilution) were used for real-time PCR with TaqMan Gene Expression Assays using an Applied Biosystems 7900HT Fast Real-Time PCR System. Standard curves for each of the 3 primer sets were constructed with serial dilutions of input DNA templates ( Supplementary  Fig. 12 ) and validated comparable amplification efficiencies (curve slopes: −3.32 to −3.64). Relative mRNA levels of Tbx18, GAPDH, and TnnT2 were obtained by extrapolation of Ct values with the slopes of the standard curve for each primer sets. Tbx18 mRNA amount in each cell was then normalized to GAPDH or TnnT2 level. Then Tbx18-NRVMs' gene expression level was normalized to that of GFP-NRVMs: 
